Bergen Brunswig Stock Rises Sharply Again

Bergen Brunswig Corp.’s stock rose for a second consecutive day after the Orange drug wholesaler said it has agreed to sell most of its money-losing specialty-medicine distribution unit to CVS Corp. The shares moved up 23%, or $1.69, to $9. On Wednesday, the stock moved up 26%, or $1.50 a share, on the New York Stock Exchange.